Previous studies reported that VEGF is able to increase ADAM10 and ADAM17 expression and activity in vitro in endothelial cells and in vivo in the brain of an AD mouse model (Donners et al., 2010; Guo et al., 2019). Here, ADAM17 is linked to Alzheimer disease.